AAAAAA

   
Results: 1-15 |
Results: 15
A COMPARISON OF 6 MONTHS WITH INDEFINITE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P
Citation: S. Schulman et al., A COMPARISON OF 6 MONTHS WITH INDEFINITE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 2379-2379
A 6-MONTH VENOGRAPHIC FOLLOW-UP IN 164 PATIENTS WITH ACUTE DEEP-VEIN THROMBOSIS
Authors: HOLMSTROM M LINDMARKER P GRANQVIST S JOHNSSON H LOCKNER D
Citation: M. Holmstrom et al., A 6-MONTH VENOGRAPHIC FOLLOW-UP IN 164 PATIENTS WITH ACUTE DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 78(2), 1997, pp. 803-807
A RETROSPECTIVE FOLLOW-UP-STUDY OF PATIENTS WITH SUSPECTED DEEP-VEIN THROMBOSIS AND NEGATIVE RESULTS OF COLOR DUPLEX ULTRASOUND
Authors: NOREN A LINDMARKER P ROSFORS S
Citation: A. Noren et al., A RETROSPECTIVE FOLLOW-UP-STUDY OF PATIENTS WITH SUSPECTED DEEP-VEIN THROMBOSIS AND NEGATIVE RESULTS OF COLOR DUPLEX ULTRASOUND, Phlebology, 12(2), 1997, pp. 56-59
THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P EKLUND SG NORDLANDER S LARFARS G LEIJD B LINDER O LOOGNA E GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J SVENSSON E DAHLIN L BOBERG J MARJANOVICS B JONSSON KA MALM C HJORTH M LINDGREN A FAGRELL B KALLNER M WADMAN B SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
ECHOCARDIOGRAPHY DOPPLER IN PULMONARY-EMBOLISM - RIGHT-VENTRICULAR DYSFUNCTION AS A PREDICTOR OF MORTALITY-RATE
Authors: RIBEIRO A LINDMARKER P JUHLINDANNFELT A JOHNSSON H JORFELDT L
Citation: A. Ribeiro et al., ECHOCARDIOGRAPHY DOPPLER IN PULMONARY-EMBOLISM - RIGHT-VENTRICULAR DYSFUNCTION AS A PREDICTOR OF MORTALITY-RATE, The American heart journal, 134(3), 1997, pp. 479-487
USE OF LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN), ONCE-DAILY, FOR THETREATMENT OF DEEP-VEIN THROMBOSIS - A FEASIBILITY AND HEALTH ECONOMIC-STUDY IN AN OUTPATIENT SETTING
Authors: LINDMARKER P HOLMSTROM M
Citation: P. Lindmarker et M. Holmstrom, USE OF LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN), ONCE-DAILY, FOR THETREATMENT OF DEEP-VEIN THROMBOSIS - A FEASIBILITY AND HEALTH ECONOMIC-STUDY IN AN OUTPATIENT SETTING, Journal of internal medicine, 240(6), 1996, pp. 395-401
THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S WIMAN B CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORTH M FAGRELL B KALLNER M GRANQVIST S EGBERG N SCHULMAN S WADMAN B SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
INFLUENCE OF CHANGES IN LIFE-STYLE ON FIBRINOLYTIC PARAMETERS AND RECURRENCE RATE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S LINDMARKER P JOHNSSON H
Citation: S. Schulman et al., INFLUENCE OF CHANGES IN LIFE-STYLE ON FIBRINOLYTIC PARAMETERS AND RECURRENCE RATE IN PATIENTS WITH VENOUS THROMBOEMBOLISM, Blood coagulation & fibrinolysis, 6(4), 1995, pp. 311-316
THE DURATION OF ORAL ANTICOAGULATION AFTER THE 1ST EVENT OF VENOUS THROMBOEMBOLISM - THE DURAC-I TRIAL
Authors: SCHULMAN S RHEDIN AS LINDMARKER P
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULATION AFTER THE 1ST EVENT OF VENOUS THROMBOEMBOLISM - THE DURAC-I TRIAL, Thrombosis and haemostasis, 73(6), 1995, pp. 1093-1093
INFLUENCE OF CHANGES IN LIFE-STYLE ON FIBRINOLYTIC PARAMETERS AND RECURRENCY RATE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: LINDMARKER P SCHULMAN S JOHNSSON H
Citation: P. Lindmarker et al., INFLUENCE OF CHANGES IN LIFE-STYLE ON FIBRINOLYTIC PARAMETERS AND RECURRENCY RATE IN PATIENTS WITH VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 73(6), 1995, pp. 1147-1147
A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S RHEDIN AS LINDMARKER P CARLSSON A LARFARS G NICOL P LOOGNA E SVENSSON E LJUNGBERG B WALTER H VIERING S NORDLANDER S LEIJD B JONSSON KA HJORTH M LINDER O BOBERG J GUSTAFSSON C GRONDAHL A TORNEBOHM E JOHANSSON M LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R WILHELMSSON S OHLSSON A MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J EKLUND SG DAHLIN L MARJANOVICS B MALM C LINDGREN A FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N WADMAN B SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN
Authors: SCHULMAN S CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORT M FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N
Citation: S. Schulman et al., QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 143-152
COMPARISON OF ONCE-DAILY SUBCUTANEOUS FRAGMIN(R) WITH CONTINUOUS INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS
Authors: LINDMARKER P HOLMSTROM M GRANQVIST S JOHNSSON H LOCKNER D
Citation: P. Lindmarker et al., COMPARISON OF ONCE-DAILY SUBCUTANEOUS FRAGMIN(R) WITH CONTINUOUS INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 72(2), 1994, pp. 186-190
FRAGMIN(R) ONCE-DAILY SUBCUTANEOUSLY IN A FIXED-DOSE COMPARED WITH CONTINUOUS INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS
Authors: LINDMARKER P HOLMSTROM M GRANQVIST S JOHNSSON H LOCKNER D
Citation: P. Lindmarker et al., FRAGMIN(R) ONCE-DAILY SUBCUTANEOUSLY IN A FIXED-DOSE COMPARED WITH CONTINUOUS INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 648-648
PATIENTS ATTITUDES AND ECONOMIC-ASPECTS ON AMBULANT TREATMENT OF ACUTE DEEP VENOUS THROMBOSIS WITH FRAGMIN ADMINISTERED SUBCUTANEOUSLY ONCE-DAILY
Authors: HOLMSTROM M LINDMARKER P WISTROM L BUHRE K KAUTTO M BERGLUND MC JOHNSSON H LOCKNER D
Citation: M. Holmstrom et al., PATIENTS ATTITUDES AND ECONOMIC-ASPECTS ON AMBULANT TREATMENT OF ACUTE DEEP VENOUS THROMBOSIS WITH FRAGMIN ADMINISTERED SUBCUTANEOUSLY ONCE-DAILY, Thrombosis and haemostasis, 69(6), 1993, pp. 651-651
Risultati: 1-15 |